11 results
8-K
EX-99.1
TRML
Tourmaline Bio Inc
14 Dec 23
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board
8:27am
cancer therapies, and grew to over $2 billion in annual revenue. During his tenure, he raised well over $1 billion in financing for Seagen from public
S-4
EX-3.3
TRML
Tourmaline Bio Inc
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
designated by the Board of Directors.
Section 29. Tenure and Duties of Officers.
(a) General. All officers will hold office at the pleasure of the Board
DEF 14A
TRML
Tourmaline Bio Inc
29 Apr 22
Definitive proxy
4:24pm
. Ildstad is also the founding director of the Institute for Cellular Therapeutics of the University of Louisville and is a Professor (with Tenure … tenure, he has participated in several drug development programs resulting in successful regulatory approvals, such as CTL-019 in pediatric ALL, the first
8-K
EX-3.2
d62 8mtnpyzw
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
424B4
t7enrux1xf7cavpjx
10 May 21
Prospectus supplement with pricing info
4:20pm
S-1/A
a62qae2 k1
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-3.4
pdbuu4bo3xt vzpci0x
3 May 21
IPO registration (amended)
6:07am
S-1
fwe9ajqmy6atbx
16 Apr 21
IPO registration
5:03pm
DRS/A
17nx4vpdkmxxq5
1 Apr 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next